Get started
OCUGEN INCOCUGEN INCOCUGEN INC

OCUGEN INC

No trades
See on Supercharts
Overview
Financials News Ideas Forecast

2H51 chart

Key stats

Market capitalization
‪300.51 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.242EUR
Net income
‪−57.15 M‬EUR
Revenue
‪5.47 M‬EUR
Shares float
‪251.67 M‬
Beta (1Y)
1.55

About OCUGEN INC

Sector
Health Technology
CEO
Shankar Musunuri
Headquarters
Malvern
Website
ocugen.com
Employees (FY)
65
Founded
2013
FIGI
BBG007PQLLS9
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange OCUGEN INC stocks are traded under the ticker 2H51.
OCUGEN INC is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
2H51 earnings for the last quarter are −0.06 EUR per share, whereas the estimation was −0.07 EUR resulting in a 14.29% surprise. The estimated earnings for the next quarter are −0.05 EUR per share. See more details about OCUGEN INC earnings.
Yes, you can track OCUGEN INC financials in yearly and quarterly reports right on TradingView.
2H51 net income for the last quarter is ‪−9.94 M‬ EUR, while the quarter before that showed ‪−13.40 M‬ EUR of net income which accounts for 25.81% change. Track more OCUGEN INC financial stats to get the full picture.
No, 2H51 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2H51 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OCUGEN INC stock right from TradingView charts — choose your broker and connect to your account.
2H51 reached its all-time high on Sep 11, 2007 with the price of 63.600 EUR, and its all-time low was 0.060 EUR and was reached on Mar 17, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 65.00 employees. See our rating of the largest employees — is OCUGEN INC on this list?
We've gathered analysts' opinions on OCUGEN INC future price: according to them, 2H51 price has a max estimate of 7.47 EUR and a min estimate of 4.67 EUR. Read a more detailed OCUGEN INC forecast: see what analysts think of OCUGEN INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OCUGEN INC EBITDA is ‪−61.12 M‬ EUR, and current EBITDA margin is ‪−1.07 K‬%. See more stats in OCUGEN INC financial statements.